EHAB Enhabit, Inc.
XNYS
13.80
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $7.58 – $14.22
- YTD
- +51.87%
- Straddle Price
- $12.00
- Market Cap
- $0.7B
- Open
- $13.79
- Day Range
- $13.79 – $13.81
- Volume
- 1,382,540
- Prev Close
- $13.79

- Industry (SIC)
- SERVICES-HOME HEALTH CARE SERVICES (8082) · industry map
- Exchange
- XNYS
- Market Cap
- $0.7B
- Employees
- 10,800
- List Date
- 2022-06-23
- CIK
- 0001803737
- Headquarters
- Dallas, TX
- Homepage
- https://www.ehab.com
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disea…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Here is my response to the stock analysis prompt:
Executive Summary
Overall Assessment: NEUTRAL (confidence level 6/10)
Key Drivers: Recent news headlines suggest a potential buyout offer, which may impact the stock's short-term price movement.
Primary Risks: The stock's low volatility and recent negative news sentiment pose risks for investors seeking significant returns.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2022-11-02 | After-Close | 6.95% | 7.83% | 1.13x | Exceeded |
| 2023-08-09 | After-Close | 17.88% | 13.80% | 0.77x | Within |
| 2023-10-05 | After-Close | 16.95% | 2.15% | 0.13x | Within |
| 2024-03-06 | After-Close | 20.48% | 22.14% | 1.08x | Exceeded |
| 2024-05-08 | After-Close | 12.37% | 14.54% | 1.18x | Exceeded |
| 2024-07-15 | After-Close | 8.43% | 5.01% | 0.59x | Within |
| 2024-11-06 | After-Close | 12.96% | 0.13% | 0.01x | Within |
| 2025-05-07 | After-Close | 12.50% | 18.17% | 1.45x | Exceeded |
| 2025-08-06 | After-Close | 16.62% | 15.21% | 0.92x | Within |
| 2025-11-05 | After-Close | 28.32% | 6.09% | 0.22x | Within |
| 2026-03-05 | After-Close | 81.37% | 0.00% | 0.00x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
EHAB Options Activity & IV Rank
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 77th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
EHAB Institutional Ownership (13F)
Latest filings — 2026-03-31Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
EHAB Insider Trading (Form 4)
Latest: 2026-05-15| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Stephan Rodgers | Director | Disp (D) | −21,338 | $13.80 | -$294.5K | EDGAR |
| 2026-05-15 | Charles M Elson | Director | Disp (D) | −80,638 | $13.80 | -$1.11M | EDGAR |
| 2026-05-15 | Jeffrey Bolton | Director | Mixed | −139,682 | $13.80 | -$1.93M | EDGAR |
| 2026-05-15 | Tina L. Brown-Stevenson | Director | Disp (D) | −52,698 | $13.80 | -$727.2K | EDGAR |
| 2026-05-15 | Ryan Solomon | Chief Financial Officer | Mixed | −193,911 | $13.80 | -$2.68M | EDGAR |
| 2026-05-15 | Mark W Ohlendorf | Director | Disp (D) | −45,867 | $13.80 | -$633.0K | EDGAR |
| 2026-05-15 | Barry P. Schochet | Director | Disp (D) | −71,930 | $13.80 | -$992.6K | EDGAR |
| 2026-05-15 | Gregory S Rush | Director | Disp (D) | −80,338 | $13.80 | -$1.11M | EDGAR |
| 2026-05-15 | Erin Hoeflinger | Director | Disp (D) | −80,405 | $13.80 | -$1.11M | EDGAR |
| 2026-05-15 | Tanya Renee Marion | Chief Human Resources Officer | Mixed | −106,763 | $13.80 | -$1.47M | EDGAR |
| 2026-05-15 | Julie Diane Jolley | EVP of Home Health Operations | Mixed | −137,130 | $13.80 | -$1.89M | EDGAR |
| 2026-05-15 | Dylan C Black | General Counsel and Secretary | Mixed | −99,823 | $13.80 | -$1.38M | EDGAR |
| 2026-05-15 | Jeanne Louise Kalvaitis | EVP of Hospice Operations | Mixed | −61,875 | $13.80 | -$853.9K | EDGAR |
| 2026-05-15 | Stuart M McGuigan | Director | Disp (D) | −75,466 | $13.80 | -$1.04M | EDGAR |
| 2026-05-15 | Barbara Ann Jacobsmeyer | President and CEO | Mixed | −606,707 | $13.80 | -$8.37M | EDGAR |
EHAB Insider Holdings
9 insiders · @ $13.80| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Jeffrey Bolton | Director | 128,682 | $1.78M | $498.9K | 23 | 2026-05-15 |
| 2 | Charles M Elson | Director | 73,412 | $1.01M | $50.1K | 13 | 2026-05-15 |
| 3 | Erin Hoeflinger | Director | 69,305 | $956.4K | $138.4K | 15 | 2026-05-15 |
| 4 | Barry P. Schochet | Director | 64,605 | $891.5K | $0 | 12 | 2026-05-15 |
| 5 | Stuart M McGuigan | Director | 60,466 | $834.4K | $132.2K | 12 | 2026-05-15 |
| 6 | Ronald Leroy Langham JR | EVP Clinical Excel. & Strategy | 58,541 | $807.9K | $114.3K | 11 | 2025-03-10 |
| 7 | Dylan C Black | General Counsel and Secretary | 34,413 | $474.9K | $0 | 10 | 2026-05-15 |
| 8 | Jeanne Louise Kalvaitis | EVP of Hospice Operations | 13,273 | $183.2K | $0 | 10 | 2026-05-15 |
| 9 | Collin McQuiddy | Chief Accounting Officer | 3,991 | $55.1K | -$28.5K | 3 | 2026-03-11 |
EHAB Board & Officers
As of SEC filings through May 15, 2026Changes in the last 10 years (45)
| May 15, 2026 | Tina L. Brown-Stevenson reported in an SEC filing no longer being a director |
| May 15, 2026 | Tanya Renee Marion reported in an SEC filing no longer being Chief Human Resources Officer |
| May 15, 2026 | Stuart M McGuigan reported in an SEC filing no longer being a director |
| May 15, 2026 | Stephan Rodgers reported in an SEC filing no longer being a director |
| May 15, 2026 | Ryan Solomon reported in an SEC filing no longer being Chief Financial Officer |
| May 15, 2026 | Mark W Ohlendorf reported in an SEC filing no longer being a director |
| May 15, 2026 | Julie Diane Jolley reported in an SEC filing no longer being EVP of Home Health Operations |
| May 15, 2026 | Jeffrey Bolton reported in an SEC filing no longer being a director |
| May 15, 2026 | Jeanne Louise Kalvaitis reported in an SEC filing no longer being EVP of Hospice Operations |
| May 15, 2026 | Gregory S Rush reported in an SEC filing no longer being a director |
| May 15, 2026 | Erin Hoeflinger reported in an SEC filing no longer being a director |
| May 15, 2026 | Dylan C Black reported in an SEC filing no longer being General Counsel and Secretary |
| May 15, 2026 | Charles M Elson reported in an SEC filing no longer being a director |
| May 15, 2026 | Barry P. Schochet reported in an SEC filing no longer being a director |
| May 15, 2026 | Barbara Ann Jacobsmeyer reported in an SEC filing no longer being a director |
| May 15, 2026 | Barbara Ann Jacobsmeyer reported in an SEC filing no longer being President and CEO |
| Feb 24, 2026 | The company announced the departure of Collin McQuiddy as Chief Accounting Officer in an SEC filing |
| Jul 1, 2025 | Stephan Rodgers became a director |
| Dec 9, 2024 | Ryan Solomon became Chief Financial Officer |
| Aug 5, 2024 | Collin McQuiddy became Chief Accounting Officer |
| Jul 25, 2024 | Mark W Ohlendorf became a director |
| Mar 30, 2023 | Stuart M McGuigan became a director |
| Mar 30, 2023 | Barry P. Schochet became a director |
| Feb 22, 2023 | Ronald Leroy Langham JR became EVP Clinical Excel. & Strategy |
| Feb 22, 2023 | Dylan C Black became General Counsel and Secretary |
| Sep 29, 2022 | The company announced the departure of Chad Keith Knight as General Counsel in an SEC filing |
| Jul 6, 2022 | Encompass Health Corp reported in an SEC filing no longer being a 10% owner |
| Jul 1, 2022 | Tina L. Brown-Stevenson became a director |
| Jul 1, 2022 | Susan LaMonica became a director |
| Jul 1, 2022 | Jeffrey Bolton became a director |
| Jul 1, 2022 | Gregory S Rush became a director |
| Jul 1, 2022 | Erin Hoeflinger became a director |
| Jun 17, 2022 | Yvonne M Curl became a director |
| Jun 17, 2022 | Tanya Renee Marion became Chief Human Resources Officer |
| Jun 17, 2022 | Leo I Higdon Jr became a director |
| Jun 17, 2022 | L Edward Shaw Jr became a director |
| Jun 17, 2022 | Julie Diane Jolley became EVP of Home Health Operations |
| Jun 17, 2022 | John E Jr D D S Maupin became a director |
| Jun 17, 2022 | Jeanne Louise Kalvaitis became EVP of Hospice Operations |
| Jun 17, 2022 | Encompass Health Corp became a 10% owner |
| Jun 17, 2022 | Crissy Buchanan Carlisle became Chief Financial Officer |
| Jun 17, 2022 | Charles M Elson became a director |
| Jun 17, 2022 | Chad Keith Knight became General Counsel |
| Jun 17, 2022 | Barbara Ann Jacobsmeyer became a director |
| Jun 17, 2022 | Barbara Ann Jacobsmeyer became President and CEO |
- Prev
- 1
Not reported recently (7)
- Ronald Leroy Langham JR · Last reported as EVP Clinical Excel. & Strategy in an SEC filing dated Mar 10, 2025
- Crissy Buchanan Carlisle · Last reported as Chief Financial Officer in an SEC filing dated Jul 3, 2024
- L Edward Shaw Jr · Last reported as a director in an SEC filing dated Jun 30, 2023
- Leo I Higdon Jr · Last reported as a director in an SEC filing dated Jun 30, 2023
- John E Jr D D S Maupin · Last reported as a director in an SEC filing dated Jun 30, 2023
- Yvonne M Curl · Last reported as a director in an SEC filing dated Jun 30, 2023
- Susan LaMonica · Last reported as a director in an SEC filing dated Jun 30, 2023
EHAB Proposed Insider Sales (Form 144)
Latest: 2026-03-11What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | McQuiddy Collin | Officer | 1,403 | $19.1K | 2026-03-11 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-03-10 | Jolley Julie Diane | Officer | 5,586 | $76.2K | 2026-03-10 | UBS Financial Services, Inc. | 10b5-1 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | MARB First Trust Merger Arbitrage ETF | Nport | 3.07% | $768,107 | — | 2026-04-30 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q1 '26 | 2026-03-31 | $264.80M | $19.20M | $0.36 | $35.20M |
| Q4 '25 | 2025-12-31 | $270.40M | $-38.70M | $-0.76 | $4.40M |
| Q3 '25 | 2025-09-30 | $263.60M | $11.10M | $0.22 | $37.80M |
| Q2 '25 | 2025-06-30 | $266.10M | $5.20M | $0.10 | $10.60M |
| Q1 '25 | 2025-03-31 | $259.90M | $17.80M | $0.35 | $17.90M |
| Q4 '24 | 2024-12-31 | $258.20M | $-46.00M | $-0.91 | $-4.10M |
| Q3 '24 | 2024-09-30 | $253.60M | $-110.20M | $-2.20 | $28.40M |
| Q2 '24 | 2024-06-30 | $260.60M | $-200.00K | — | $9.60M |
| Q1 '24 | 2024-03-31 | $262.40M | $200.00K | $0.01 | $17.30M |
| Q4 '23 | 2023-12-31 | $260.60M | $-6.40M | $-0.13 | $2.90M |
| Q3 '23 | 2023-09-30 | $258.30M | $-2.40M | $-0.05 | $6.30M |
| Q2 '23 | 2023-06-30 | $262.30M | $-74.40M | $-1.49 | $9.60M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.